Age as a predictor of outcomes following stereotactic radiosurgery for metastatic disease to the brain

Presenter Information

Thomas Lucido, Drexel College of MedicineFollow
Anne Glenney, Drexel College of MedicineFollow
Shahed Elhamdani MD, Allegheny General Hospital Department of NeurosurgeryFollow
Rodney Wegner MD, Allegheny General Hospital Department of Radiation OncologyFollow
Matthew Shepard MD, Allegheny General Hospital Department of NeurosurgeryFollow

Presentation Type

Clinical Research

Recommended Citation

Lucido, Thomas; Glenney, Anne; Elhamdani, Shahed MD; Wegner, Rodney MD; and Shepard, Matthew MD, "Age as a predictor of outcomes following stereotactic radiosurgery for metastatic disease to the brain" (2022). St. Chris Research Day. 18.
https://scholarcommons.towerhealth.org/schc_researchday/2022/clinical_research/18